IDEAS home Printed from https://ideas.repec.org/
MyIDEAS: Log in (now much improved!)

Citations for "Adjusting the Value of a Statistical Life for Age and Cohort Effects"

by Aldy, Joseph E. & Viscusi, W. Kip

For a complete description of this item, click here. For a RSS feed for citations of this item, click here.
as
in new window

  1. Thomas J. Kniesner & W. Kip Viscusi & James P. Ziliak, 2009. "Policy Relevant Heterogeneity in the Value of Statistical Life: New Evidence from Panel Data Quantile Regressions," Center for Policy Research Working Papers 118, Center for Policy Research, Maxwell School, Syracuse University.
  2. Aldy, Joseph E. & Viscusi, W. Kip, 2007. "Age Differences in the Value of Statistical Life: Revealed Preference Evidence," Discussion Papers dp-07-05, Resources For the Future.
  3. Hostenkamp, Gisela & Lichtenberg, Frank R., 2015. "The impact of recent chemotherapy innovation on the longevity of myeloma patients: US and international evidence," Social Science & Medicine, Elsevier, vol. 130(C), pages 162-171.
  4. Hammitt, James, 2017. "Valuing Non-fatal Health Risks: Monetary and Health-Utility Measures," TSE Working Papers 17-757, Toulouse School of Economics (TSE).
  5. Bommier, Antoine & Villeneuve, Bertrand, 2008. "Risk Aversion and the Value of Risk to Life," MPRA Paper 11943, University Library of Munich, Germany.
  6. Svensson, Mikael, 2006. "The Value of a Statistical Life in Sweden Estimates from Two Studies using the "Certainty Approach" Calibration," Working Papers 2006:6, Örebro University, School of Business, revised 25 Jul 2007.
  7. Rheinberger, Christoph M. & Hammitt, James K., 2014. "The welfare value of FDA's mercury-in-fish advisory: A dynamic reanalysis," Journal of Health Economics, Elsevier, vol. 37(C), pages 113-122.
  8. Ryan D. Edwards, 2008. "The Cost of Uncertain Life Span," NBER Working Papers 14093, National Bureau of Economic Research, Inc.
  9. Aldy, Joseph Edgar & Smyth, Seamus J, 2014. "Heterogeneity in the Value of Life," Scholarly Articles 23017248, Harvard Kennedy School of Government.
  10. W. Viscusi, 2008. "How to value a life," Journal of Economics and Finance, Springer;Academy of Economics and Finance, vol. 32(4), pages 311-323, October.
  11. Cameron, Trudy Ann & DeShazo, J.R., 2013. "Demand for health risk reductions," Journal of Environmental Economics and Management, Elsevier, vol. 65(1), pages 87-109.
  12. W. Kip Viscusi, 2014. "The Role of Publication Selection Bias in Estimates of the Value of a Statistical Life," NBER Working Papers 20116, National Bureau of Economic Research, Inc.
  13. Frank Lichtenberg, 2015. "Pharmaceutical Innovation, Longevity, and Medical Expenditure in Greece, 1995-2010," CESifo Working Paper Series 5166, CESifo Group Munich.
  14. van Benthem, Arthur, 2015. "What is the optimal speed limit on freeways?," Journal of Public Economics, Elsevier, vol. 124(C), pages 44-62.
  15. James Hammitt & Tuba Tunçel, 2015. "Preferences for life-expectancy gains: Sooner or later?," Journal of Risk and Uncertainty, Springer, vol. 51(1), pages 79-101, August.
  16. Amitabh Chandra & Jonathan S. Skinner, 2011. "Technology Growth and Expenditure Growth in Health Care," NBER Working Papers 16953, National Bureau of Economic Research, Inc.
  17. Michael Jones-Lee & Susan Chilton & Hugh Metcalf & Jytte Nielsen, 2015. "Valuing gains in life expectancy: Clarifying some ambiguities," Journal of Risk and Uncertainty, Springer, vol. 51(1), pages 1-21, August.
  18. James Hammitt, 2013. "Admissible utility functions for health, longevity, and wealth: integrating monetary and life-year measures," Journal of Risk and Uncertainty, Springer, vol. 47(3), pages 311-325, December.
  19. Gentry, Elissa Philip & Viscusi, W. Kip, 2016. "The fatality and morbidity components of the value of statistical life," Journal of Health Economics, Elsevier, vol. 46(C), pages 90-99.
  20. Julien Hugonnier & Florian Pelgrin & Pascal St-Amour, 2010. "A structural analysis of the health expenditures and portfolio choices of retired agents," Swiss Finance Institute Research Paper Series 10-29, Swiss Finance Institute.
  21. Abou-Ali, Hala & El-Azony, Hesham & El-Laithy, Heba & Haughton, Jonathan & Khandker, Shahidur R., 2009. "Evaluating the impact of Egyptian social fund for development programs," Policy Research Working Paper Series 4993, The World Bank.
  22. Frankovic, Ivan & Kuhn, Michael & Wrzaczek, Stefan, 2016. "Medical care within an OLG economy with realistic demography," ECON WPS - Vienna University of Technology Working Papers in Economic Theory and Policy 02/2016, Vienna University of Technology, Institute for Mathematical Methods in Economics, Research Group Economics (ECON).
  23. The Untold Standards of Living Story: The GDP value of Twentieth Century Health Improvements in Developed Economies, 2012. "Hickson, Kerry," CAGE Online Working Paper Series 105, Competitive Advantage in the Global Economy (CAGE).
  24. Hammitt, James & Roman, Henry & Stieb, David & Walsh, Tyra, 2012. "Expert Elicitation of the Value per Statistical Life in an Air Pollution Context," TSE Working Papers 12-290, Toulouse School of Economics (TSE).
  25. Jytte Nielsen & Susan Chilton & Michael Jones-Lee & Hugh Metcalf, 2010. "How would you like your gain in life expectancy to be provided? An experimental approach," Journal of Risk and Uncertainty, Springer, vol. 41(3), pages 195-218, December.
  26. Brajer, Victor & Mead, Robert W. & Xiao, Feng, 2008. "Health benefits of tunneling through the Chinese environmental Kuznets curve (EKC)," Ecological Economics, Elsevier, vol. 66(4), pages 674-686, July.
  27. Thomas J. Kniesner & W. Kip Viscusi & Christopher Woock & James P. Ziliak, 2010. "The Value of a Statistical Life: Evidence from Panel Data," Center for Policy Research Working Papers 122, Center for Policy Research, Maxwell School, Syracuse University.
  28. Damien Sheehan-Connor & Theodore Bergstrom & Rodney Garratt, 2015. "Saving lives with stem cell transplants," Journal of Risk and Uncertainty, Springer, vol. 51(1), pages 23-51, August.
  29. Restrepo, Brandon J. & Rieger, Matthias, 2016. "Trans fat and cardiovascular disease mortality: Evidence from bans in restaurants in New York," Journal of Health Economics, Elsevier, vol. 45(C), pages 176-196.
  30. Parry, Ian W.H. & Laxminarayan, Ramanan & West, Sarah E., 2006. "Fiscal and Externality Rationales for Alcohol Taxes," Discussion Papers dp-06-51, Resources For the Future.
  31. Chandra Amitabh & MacEwan Joanna P. & Campinha-Bacote Avrita & Khan Zeba M., 2016. "Returns to Society from Investment in Cancer Research and Development," Forum for Health Economics & Policy, De Gruyter, vol. 19(1), pages 71-86, June.
  32. Kochi Ikuho & Taylor Laura O, 2011. "Risk Heterogeneity and the Value of Reducing Fatal Risks: Further Market-Based Evidence," Journal of Benefit-Cost Analysis, De Gruyter, vol. 2(3), pages 1-28, August.
  33. Martin Lauren & Lotspeich Richard, 2014. "A benefit-cost framework for early intervention to prevent sex trading," Journal of Benefit-Cost Analysis, De Gruyter, vol. 5(1), pages 1-45, January.
  34. Frank Lichtenberg, 2015. "The Impact of Pharmaceutical Innovation on Premature Mortality, Cancer Mortality, and Hospitalization in Slovenia, 1997–2010," Applied Health Economics and Health Policy, Springer, vol. 13(2), pages 207-222, April.
  35. W. Viscusi & Elissa Gentry, 2015. "The value of a statistical life for transportation regulations: A test of the benefits transfer methodology," Journal of Risk and Uncertainty, Springer, vol. 51(1), pages 53-77, August.
  36. Trudy Cameron & J. DeShazo & Peter Stiffler, 2010. "Demand for health risk reductions: A cross-national comparison between the U.S. and Canada," Journal of Risk and Uncertainty, Springer, vol. 41(3), pages 245-273, December.
  37. Lichtenberg, Frank R., 2014. "The impact of pharmaceutical innovation on longevity and medical expenditure in France, 2000–2009," Economics & Human Biology, Elsevier, vol. 13(C), pages 107-127.
  38. Mary Evans & V. Kerry Smith, 2008. "Complementarity and the Measurement of Individual Risk Tradeoffs: Accounting for Quantity and Quality of Life Effects," Environmental & Resource Economics, Springer;European Association of Environmental and Resource Economists, vol. 41(3), pages 381-400, November.
  39. Andersson, Henrik, 2006. "Willingness to Pay for Road Safety and Estimates of the Risk of Death: Evidence from a Swedish Contingent Valuation Study," Working Papers 2006:5, Swedish National Road & Transport Research Institute (VTI).
  40. James Hammitt & Kevin Haninger, 2010. "Valuing fatal risks to children and adults: Effects of disease, latency, and risk aversion," Journal of Risk and Uncertainty, Springer, vol. 40(1), pages 57-83, February.
  41. Swensen, Isaac D., 2015. "Substance-abuse treatment and mortality," Journal of Public Economics, Elsevier, vol. 122(C), pages 13-30.
  42. Lichtenberg, Frank R. & Tatar, Mehtap & Çalışkan, Zafer, 2014. "The effect of pharmaceutical innovation on longevity, hospitalization and medical expenditure in Turkey, 1999–2010," Health Policy, Elsevier, vol. 117(3), pages 361-373.
  43. Clapp, John M. & Eichholtz, Piet & Lindenthal, Thies, 2013. "Real option value over a housing market cycle," Regional Science and Urban Economics, Elsevier, vol. 43(6), pages 862-874.
  44. Hammitt, James & Herrera-Araujo, Daniel, 2017. "Peeling back the onion: Using latent class analysis to uncover heterogeneous responses to stated preference surveys," TSE Working Papers 17-766, Toulouse School of Economics (TSE).
This information is provided to you by IDEAS at the Research Division of the Federal Reserve Bank of St. Louis using RePEc data.